Navigation Links
Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
Date:8/22/2007

> 2002.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.

Forward-Looking Statements

This release contains information about management's view of Kendle's future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including, but not limited to, those set forth in the "Risk Factors" section of the Company's latest Form 10-K and other filings with the Sec
'/>"/>

SOURCE Kendle International Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Summer marks countdown to DEMOfall
2. Digital Healthcare Conference marks Wisconsins Healthcare IT Week
3. Biomedical alliance marks first full year
4. Bone Care marks solid quarter on Hectorol sales jump
5. Global branding is easy with global trademarks
6. Furious pace of Midwest biotech events marks progress
7. SupraNet marks off 10 years as an Internet service provider
8. Recent developments in the protection of trademarks on the Internet
9. High Tech Happy Hour will mark fourth anniversary
10. Its All Fun And Games in Madison - Raven Software Celebrates 15 Anniversary
11. 2006: A great biotech financing year, unless you were going public!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
Breaking Biology Technology:Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4
...21 NovaRx Corporation announced today,that the co...al of,Lucanix(R) (belagenpumatucel-L) in the treat...). The first patient enrolled in the study was tre...al investigator at the University,of California, S....newscom.com/cgi-bin/prnh/20080821/LATH009-a ), (...
...uctor silicon and the ferromagnet iron are the bas...thing from computers to electric motors. In this w...an international group of scientists, including ac... and Lesotho, report that they have combined these...tal, manganese, to create a new material which is ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq...d a letter from The Nasdaq,Stock Market on August ...ly,with the requirements for continued listing on ...the maintenance standard that specifies, among,oth...n,s common stock be at,least $50 million as requir...
Other Biology Technology:NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 2NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 3NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 4Creating unconventional metals 2Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market 2Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market 3
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
(Date:12/3/2009)In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to dege
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How nutrition affects healthy aging 2Papillomavirus silences innate immune response 2Hospital Workers May Trigger Dangerous Outbreaks 59765 1Hospital Workers May Trigger Dangerous Outbreaks 59765 2Hospital Workers May Trigger Dangerous Outbreaks 59765 3Detecting the undetectable in prostate cancer screening 59761 1Detecting the undetectable in prostate cancer screening 59761 2Detecting the undetectable in prostate cancer screening 59761 3Detecting the undetectable in prostate cancer screening 59761 4GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 1GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 2GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 3GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 4
...ody good,?radiologists are testing use of the dair...maging exams—with excellent results. The researche...ting of the Radiological Society of North America ...stension and enhancement as we see with the common...h-Patel, M.D., a radiology resident at St. Luke’s-...
...y one day help physicians detect cancerous tumors ...ows nanoparticles to group together inside cancero...ic signal to be detectable by a magnetic resonance... cover feature in the May issue of Angewandte Chem...ng chemistry journals. , The research, which is j...
...nto the genome of fruit flies or Drosophila ?promi...y the structure and function of virtually all the ...ther frequently studied organisms such as mice, sa... article in the current issue of the journal Scien...ently available methods because it allows you to s...
Other Biology News:Got inexpensive contrast agent? Milk plays new role in imaging 2MIT nanoparticles may help detect, treat tumors 2P(acman) takes a bite out of deciphering Drosophila DNA 2
Rat Anti-Mouse P-Selectin / CD62P Monoclonal Antibody, Unconjugated, Clone 127933 from R&D Systems
Rat Leptin from Cell Sciences
Cat IgA ELISA Kit from Bethyl Laboratories
Cat IgM ELISA Kit from Bethyl Laboratories
Biology Products: